These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

844 related articles for article (PubMed ID: 25606362)

  • 61. Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model.
    Goebel-Goody SM; Wilson-Wallis ED; Royston S; Tagliatela SM; Naegele JR; Lombroso PJ
    Genes Brain Behav; 2012 Jul; 11(5):586-600. PubMed ID: 22405502
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Negative Effects of Chronic Rapamycin Treatment on Behavior in a Mouse Model of Fragile X Syndrome.
    Saré RM; Song A; Loutaev I; Cook A; Maita I; Lemons A; Sheeler C; Smith CB
    Front Mol Neurosci; 2017; 10():452. PubMed ID: 29375310
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fragile X mice: reduced long-term potentiation and N-Methyl-D-Aspartate receptor-mediated neurotransmission in dentate gyrus.
    Yun SH; Trommer BL
    J Neurosci Res; 2011 Feb; 89(2):176-82. PubMed ID: 21162125
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures.
    Myrick LK; Deng PY; Hashimoto H; Oh YM; Cho Y; Poidevin MJ; Suhl JA; Visootsak J; Cavalli V; Jin P; Cheng X; Warren ST; Klyachko VA
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):949-56. PubMed ID: 25561520
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening.
    Handt M; Epplen A; Hoffjan S; Mese K; Epplen JT; Dekomien G
    Mol Cell Probes; 2014; 28(5-6):279-83. PubMed ID: 25171808
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sensory Processing Phenotypes in Fragile X Syndrome.
    Rais M; Binder DK; Razak KA; Ethell IM
    ASN Neuro; 2018; 10():1759091418801092. PubMed ID: 30231625
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The effect of single-cell knockout of Fragile X Messenger Ribonucleoprotein on synaptic structural plasticity.
    Gredell M; Lu J; Zuo Y
    Front Synaptic Neurosci; 2023; 15():1135479. PubMed ID: 37035256
    [TBL] [Abstract][Full Text] [Related]  

  • 68. GABA Measurement in a Neonatal Fragile X Syndrome Mouse Model Using
    Reyes ST; Mohajeri S; Krasinska K; Guo SG; Gu M; Pisani L; Rosenberg J; Spielman DM; Chin FT
    Front Mol Neurosci; 2020; 13():612685. PubMed ID: 33390902
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Event-related potential alterations in fragile X syndrome.
    Knoth IS; Lippé S
    Front Hum Neurosci; 2012; 6():264. PubMed ID: 23015788
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacological Reactivation of the Silenced
    Kumari D; Gazy I; Usdin K
    Brain Sci; 2019 Feb; 9(2):. PubMed ID: 30759772
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Epigenetic insights into Fragile X Syndrome.
    Xie L; Li H; Xiao M; Chen N; Zang X; Liu Y; Ye H; Tang C
    Front Cell Dev Biol; 2024; 12():1432444. PubMed ID: 39220684
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comprehensive motor testing in Fmr1-KO mice exposes temporal defects in oromotor coordination.
    Roy S; Zhao Y; Allensworth M; Farook MF; LeDoux MS; Reiter LT; Heck DH
    Behav Neurosci; 2011 Dec; 125(6):962-9. PubMed ID: 22004265
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genetic reduction of MMP-9 in the Fmr1 KO mouse partially rescues prepulse inhibition of acoustic startle response.
    Kokash J; Alderson EM; Reinhard SM; Crawford CA; Binder DK; Ethell IM; Razak KA
    Brain Res; 2019 Sep; 1719():24-29. PubMed ID: 31128097
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characterization of ultrasonic vocalizations of Fragile X mice.
    Belagodu AP; Johnson AM; Galvez R
    Behav Brain Res; 2016 Sep; 310():76-83. PubMed ID: 27142239
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fragile X syndrome.
    Hagerman RJ; Berry-Kravis E; Hazlett HC; Bailey DB; Moine H; Kooy RF; Tassone F; Gantois I; Sonenberg N; Mandel JL; Hagerman PJ
    Nat Rev Dis Primers; 2017 Sep; 3():17065. PubMed ID: 28960184
    [TBL] [Abstract][Full Text] [Related]  

  • 76. iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth.
    Doers ME; Musser MT; Nichol R; Berndt ER; Baker M; Gomez TM; Zhang SC; Abbeduto L; Bhattacharyya A
    Stem Cells Dev; 2014 Aug; 23(15):1777-87. PubMed ID: 24654675
    [TBL] [Abstract][Full Text] [Related]  

  • 77. AAV-delivered diacylglycerol kinase DGKk achieves long-term rescue of fragile X syndrome mouse model.
    Habbas K; Cakil O; Zámbó B; Tabet R; Riet F; Dembele D; Mandel JL; Hocquemiller M; Laufer R; Piguet F; Moine H
    EMBO Mol Med; 2022 May; 14(5):e14649. PubMed ID: 35373916
    [TBL] [Abstract][Full Text] [Related]  

  • 78. GABA
    Schaefer TL; Ashworth AA; Tiwari D; Tomasek MP; Parkins EV; White AR; Snider A; Davenport MH; Grainger LM; Becker RA; Robinson CK; Mukherjee R; Williams MT; Gibson JR; Huber KM; Gross C; Erickson CA
    Front Psychiatry; 2021; 12():678090. PubMed ID: 34093287
    [TBL] [Abstract][Full Text] [Related]  

  • 79. eIF4E/Fmr1 double mutant mice display cognitive impairment in addition to ASD-like behaviors.
    Huynh TN; Shah M; Koo SY; Faraud KS; Santini E; Klann E
    Neurobiol Dis; 2015 Nov; 83():67-74. PubMed ID: 26306459
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Investigating cell-specific effects of FMRP deficiency on spiny projection neurons in a mouse model of Fragile X syndrome.
    Giua G; Lassalle O; Makrini-Maleville L; Valjent E; Chavis P; Manzoni OJJ
    Front Cell Neurosci; 2023; 17():1146647. PubMed ID: 37323585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.